About the journal

Clinical & Molecular Biomedicine (CMB) publishes innovative research that advances understanding of disease mechanisms and clinical interventions. The primary aim of CMB is to publish studies that explain the molecular mechanisms underlying human diseases and translate these findings into clinically meaningful outcomes. The journal welcomes interdisciplinary studies combining experimental, computational, and clinical research approaches. Major Research Themes: Genomics and Epigenetics Identification of disease-associated genetic variants and epigenetic modifications. Proteomics and Metabolomics Discovery of molecular biomarkers and metabolic pathways associated with disease. Translational Oncology Research focusing on cancer biomarkers, molecular diagnostics, and targeted therapies. Molecular Neurobiology Studies investigating molecular mechanisms of neurological disorders. Biomarker Discovery Identification and validation of diagnostic, prognostic, and therapeutic biomarkers. Drug Target Discovery Research identifying novel molecular targets for therapeutic intervention. Precision Medicine Integration of molecular data for personalized therapeutic strategies. Article Types: The journal accepts several categories of manuscripts. Original Research Articles Full-length reports describing novel experimental or clinical findings. Review Articles Comprehensive and critical reviews summarizing current knowledge in a specific field. Short Communications Brief reports presenting important preliminary findings. Case Reports Clinical observations offering novel insights into disease or treatment. Methods and Protocols Descriptions of new techniques or improved experimental methodologies. Letters to the Editor Comments or discussions related to previously published articles.

Read full aims & scope